Embryonal Carcinoma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Therapy to Treat Ewing's Sarcoma, Rhabdomyosarcoma or Neuroblastoma
Conditions: Neuroblastoma; Sarcoma; Rhabdomyosarcoma-Embryonal; Rhabdomyosarcoma- Alveolar; Neuroectodermal Tumors, Primitive, PeripheralInterventions: Drug: Tumor Purged/CD25 Depleted Lymphocytes; Biological: Tumor Purged/CD25 Depleted Lymphocytes with Tumor Lysate/KLH Pulsed Dendritic Cell Vaccine; Drug: rhIL-7; Biological: Tumor Lysate/KLH Pulsed Dendritic Cell VaccineSponsor: National Cancer Institute (NCI)Suspended - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 17, 2009 Category: Research Source Type: clinical trials

Vorinostat Combined With Isotretinoin and Chemotherapy in Treating Younger Patients With Embryonal Tumors of the Central Nervous System
Conditions: Untreated Childhood Medulloblastoma; Untreated Childhood Supratentorial Primitive Neuroectodermal TumorInterventions: Radiation: 3-Dimensional Conformal Radiation Therapy; Drug: Cisplatin; Drug: Cyclophosphamide; Drug: Isotretinoin; Other: Laboratory Biomarker Analysis; Procedure: Peripheral Blood Stem Cell Transplantation; Drug: Thiotepa; Drug: Vincristine Sulfate; Drug: VorinostatSponsor: National Cancer Institute (NCI)Active, not recruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2009 Category: Research Source Type: clinical trials

Vorinostat Combined With Isotretinoin and Chemotherapy in Treating Younger Patients With Embryonal Tumors of the Central Nervous System
Conditions: Untreated Childhood Medulloblastoma; Untreated Childhood Supratentorial Primitive Neuroectodermal TumorInterventions: Drug: Vorinostat; Drug: Isotretinoin; Drug: Vincristine Sulfate; Drug: Cisplatin; Drug: Cyclophosphamide; Drug: Thiotepa; Procedure: Peripheral Blood Stem Cell Transplantation; Radiation: 3-Dimensional Conformal Radiation Therapy; Other: Laboratory Biomarker AnalysisSponsor: National Cancer Institute (NCI)Active, not recruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2009 Category: Research Source Type: clinical trials

Vorinostat Combined With Isotretinoin and Chemotherapy in Treating Younger Patients With Embryonal Tumors of the Central Nervous System
Conditions: Untreated Childhood Medulloblastoma; Untreated Childhood Supratentorial Primitive Neuroectodermal TumorInterventions: Drug: vorinostat; Drug: isotretinoin; Drug: vincristine sulfate; Drug: cisplatin; Drug: cyclophosphamide; Drug: thiotepa; Procedure: peripheral blood stem cell transplantation; Radiation: 3-dimensional conformal radiation therapy; Other: laboratory biomarker analysisSponsor: National Cancer Institute (NCI)Active, not recruiting - verified June 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2009 Category: Research Source Type: clinical trials

Vorinostat Combined With Isotretinoin and Chemotherapy in Treating Younger Patients With Embryonal Tumors of the Central Nervous System
Conditions: Untreated Childhood Medulloblastoma; Untreated Childhood Supratentorial Primitive Neuroectodermal TumorInterventions: Drug: Vorinostat; Drug: Isotretinoin; Drug: Vincristine Sulfate; Drug: Cisplatin; Drug: Cyclophosphamide; Drug: Thiotepa; Procedure: Peripheral Blood Stem Cell Transplantation; Radiation: 3-Dimensional Conformal Radiation Therapy; Other: Laboratory Biomarker AnalysisSponsor: National Cancer Institute (NCI)Active, not recruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2009 Category: Research Source Type: clinical trials

Vorinostat Combined With Isotretinoin and Chemotherapy in Treating Younger Patients With Embryonal Tumors of the Central Nervous System
Conditions: Untreated Childhood Medulloblastoma; Untreated Childhood Supratentorial Primitive Neuroectodermal TumorInterventions: Drug: vorinostat; Drug: isotretinoin; Drug: vincristine sulfate; Drug: cisplatin; Drug: cyclophosphamide; Drug: thiotepa; Procedure: peripheral blood stem cell transplantation; Radiation: 3-dimensional conformal radiation therapy; Other: laboratory biomarker analysisSponsor: National Cancer Institute (NCI)Recruiting - verified June 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 20, 2009 Category: Research Source Type: clinical trials